AKEBIA THERAPEUTICS
AKBA Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-09
2025-06-11
MALABRE RICHARD
SVP, Chief Accounting Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$934.98M
2025-06-09
2025-06-11
MALABRE RICHARD
SVP, Chief Accounting Officer
M - Exercise
Stock Option (Right to buy)
-15,000
$0.00
1
$934.98M
2025-06-09
2025-06-11
MALABRE RICHARD
SVP, Chief Accounting Officer
S - Sale
Common Stock
-15,000
$4.00
-60,000
1
$934.98M
2025-06-04
2025-06-05
MALABRE RICHARD
SVP, Chief Accounting Officer
S - Sale
Common Stock
-13,334
$4.00
-53,336
1
$934.98M
2025-03-03
2025-03-04
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-46,409
$2.00
-92,818
1
$934.98M
2025-03-03
2025-03-04
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,144
$2.00
-14,288
1
$934.98M
2025-02-03
2025-02-04
GRUND NICHOLAS
Chief Commercial Officer
S - Sale
Common Stock
-55,621
$2.00
-111K
1
$934.98M
2025-02-03
2025-02-04
MALABRE RICHARD
SVP, Chief Accounting Officer
S - Sale
Common Stock
-30,202
$2.00
-60,404
1
$934.98M
2025-02-03
2025-02-04
MALABRE RICHARD
SVP, Chief Accounting Officer
S - Sale
Common Stock
-30,202
$2.00
-60,404
1
$934.98M
2025-02-03
2025-02-04
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-50,506
$2.00
-101K
2
$934.98M
2025-02-03
2025-02-04
GRUND NICHOLAS
Chief Commercial Officer
S - Sale
Common Stock
-55,621
$2.00
-111K
1
$934.98M
2025-02-03
2025-02-04
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-50,506
$2.00
-101K
2
$934.98M
2025-01-31
2025-02-04
GRUND NICHOLAS
Chief Commercial Officer
A - Grant
Stock Option (Right to buy)
292K
$0.00
1
$934.98M
2025-01-31
2025-02-04
BUTLER JOHN
CEO and President
A - Grant
Performance Stock Units
351K
$0.00
1
$934.98M
2025-01-31
2025-02-04
BUTLER JOHN
CEO and President
A - Grant
Stock Option (Right to buy)
1.05M
$0.00
1
$934.98M
2025-01-31
2025-02-04
GRUND NICHOLAS
Chief Commercial Officer
A - Grant
Common Stock
195K
$0.00
1
$934.98M
2025-01-31
2025-02-04
MALABRE RICHARD
SVP, Chief Accounting Officer
A - Grant
Stock Option (Right to buy)
128K
$0.00
1
$934.98M
2025-01-31
2025-02-04
MALABRE RICHARD
SVP, Chief Accounting Officer
A - Grant
Common Stock
85,000
$0.00
1
$934.98M
2025-01-31
2025-02-04
OSTROWSKI ERIK
SVP, CFO, CBO & Treasurer
A - Grant
Stock Option (Right to buy)
292K
$0.00
1
$934.98M
2025-01-31
2025-02-04
OSTROWSKI ERIK
SVP, CFO, CBO & Treasurer
A - Grant
Common Stock
195K
$0.00
1
$934.98M
2025-01-31
2025-02-04
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to buy)
292K
$0.00
1
$934.98M
2025-01-31
2025-02-04
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
195K
$0.00
1
$934.98M
2024-06-28
2024-07-02
OSTROWSKI ERIK
SVP, CFO, CBO & Treasurer
A - Grant
Common Stock
350K
$0.00
1
$934.98M
2024-06-28
2024-07-02
OSTROWSKI ERIK
SVP, CFO, CBO & Treasurer
A - Grant
Stock Option (Right to buy)
500K
$0.00
1
$934.98M
2024-05-13
2024-05-14
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-34,840
$1.00
-34,840
1
$934.98M
2024-05-13
2024-05-14
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-12,016
$1.00
-12,016
1
$934.98M
2023-08-25
2024-05-09
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-27,000
$1.00
-27,000
1
$934.98M
2024-02-29
2024-03-01
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-5,974
$2.00
-11,948
1
$934.98M
2024-02-29
2024-03-01
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-46,570
$2.00
-93,140
1
$934.98M
2024-02-29
2024-03-01
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,169
$2.00
-14,338
1
$934.98M
2024-02-29
2024-03-01
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-8,661
$2.00
-17,322
1
$934.98M
2024-02-27
2024-02-29
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-10,744
$2.00
-21,488
1
$934.98M
2024-02-27
2024-02-29
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-8,367
$2.00
-16,734
1
$934.98M
2024-02-27
2024-02-29
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-37,733
$2.00
-75,466
1
$934.98M
2024-02-27
2024-02-29
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-7,411
$2.00
-14,822
1
$934.98M
2024-02-01
2024-02-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-24,311
$2.00
-48,622
1
$934.98M
2024-02-01
2024-02-02
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-46,489
$2.00
-92,978
1
$934.98M
2024-01-31
2024-02-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to buy)
303K
$0.00
1
$934.98M
2024-01-31
2024-02-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
202K
$0.00
1
$934.98M
2024-01-31
2024-02-02
BUTLER JOHN
CEO and President
A - Grant
Stock Option (Right to buy)
905K
$0.00
1
$934.98M
2024-01-31
2024-02-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Stock Option (Right to buy)
224K
$0.00
1
$934.98M
2024-01-31
2024-02-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
149K
$0.00
1
$934.98M
2024-01-31
2024-02-02
GRUND NICHOLAS
Chief Commercial Officer
A - Grant
Stock Option (Right to buy)
455K
$0.00
1
$934.98M
2024-01-31
2024-02-02
GRUND NICHOLAS
Chief Commercial Officer
A - Grant
Common Stock
303K
$0.00
1
$934.98M
2024-01-31
2024-02-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Stock Option (Right to buy)
224K
$0.00
1
$934.98M
2024-01-31
2024-02-02
MALABRE RICHARD
Chief Accounting Officer
A - Grant
Stock Option (Right to buy)
336K
$0.00
1
$934.98M
2024-01-31
2024-02-02
MALABRE RICHARD
Chief Accounting Officer
A - Grant
Common Stock
224K
$0.00
1
$934.98M
2024-01-31
2024-02-02
SNOW ELLEN
SVP, CFO and Treasurer
A - Grant
Stock Option (Right to buy)
224K
$0.00
1
$934.98M
2023-07-31
2023-08-01
SNOW ELLEN
SVP, CFO and Treasurer
A - Grant
Stock Option (Right to buy)
560K
$0.00
1
$934.98M
2023-05-25
2023-05-25
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-95,478
$1.00
-95,478
1
$934.98M
2023-05-25
2023-05-25
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-63,186
$1.00
-63,186
1
$934.98M
2023-05-24
2023-05-25
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Employee Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2023-05-24
2023-05-25
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
200K
$0.00
1
$934.98M
2023-05-24
2023-05-25
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Employee Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2023-05-16
2023-05-18
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-63,567
$1.00
-63,567
1
$934.98M
2023-05-16
2023-05-18
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-63,567
$1.00
-63,567
1
$934.98M
2023-05-12
2023-05-16
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
200K
$0.00
1
$934.98M
2023-03-01
2023-03-03
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-14,123
$1.00
-14,123
3
$934.98M
2023-03-01
2023-03-03
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-91,868
$1.00
-91,868
3
$934.98M
2023-03-01
2023-03-03
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-20,412
$1.00
-20,412
3
$934.98M
2023-03-01
2023-03-03
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-13,034
$1.00
-13,034
3
$934.98M
2023-03-01
2023-03-03
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-7,210
$1.00
-7,210
2
$934.98M
2023-02-27
2023-03-01
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-10,090
$1.00
-10,090
1
$934.98M
2023-02-27
2023-03-01
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,539
$1.00
-7,539
1
$934.98M
2023-02-27
2023-03-01
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-38,632
$1.00
-38,632
1
$934.98M
2023-02-27
2023-03-01
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-6,677
$1.00
-6,677
1
$934.98M
2023-02-27
2023-03-01
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-7,539
$1.00
-7,539
1
$934.98M
2023-01-31
2023-02-02
BUTLER JOHN
CEO and President
A - Grant
Stock Option (Right to buy)
875K
$0.00
1
$934.98M
2023-01-31
2023-02-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
196K
$0.00
1
$934.98M
2023-01-31
2023-02-02
BUTLER JOHN
CEO and President
A - Grant
Stock Appreciation Right
635K
$0.00
1
$934.98M
2023-01-31
2023-02-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to buy)
294K
$0.00
1
$934.98M
2023-01-31
2023-02-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Stock Option (Right to buy)
294K
$0.00
1
$934.98M
2022-08-31
2022-09-01
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-1,147
$0.00
1
$934.98M
2022-06-08
2022-06-10
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2022-05-12
2022-05-16
COTREAU VIOLETTA
SVP, Chief Accounting Officer
A - Grant
Common Stock
150K
$0.00
1
$934.98M
2022-05-12
2022-05-16
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2022-05-12
2022-05-16
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
200K
$0.00
1
$934.98M
2022-03-01
2022-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-803
$2.00
-1,606
1
$934.98M
2022-03-01
2022-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-14,978
$2.00
-29,956
3
$934.98M
2022-03-01
2022-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,656
$2.00
-15,312
2
$934.98M
2022-03-01
2022-03-02
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-14,507
$2.00
-29,014
3
$934.98M
2022-02-28
2022-03-02
BUTLER JOHN
CEO and President
A - Grant
Employee Stock Option (Right to buy)
740K
$0.00
1
$934.98M
2022-02-28
2022-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Common Stock
50,000
$0.00
1
$934.98M
2022-02-28
2022-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Employee Stock Option (Right to buy)
225K
$0.00
1
$934.98M
2022-02-28
2022-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Common Stock
60,000
$0.00
1
$934.98M
2022-02-28
2022-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,400
$2.00
-14,800
1
$934.98M
2022-02-28
2022-03-02
BUTLER JOHN
CEO and President
S - Sale
Common Stock
-25,053
$2.00
-50,106
1
$934.98M
2022-02-28
2022-03-02
COTREAU VIOLETTA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-3,946
$2.00
-7,892
1
$934.98M
2022-02-28
2022-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-6,555
$2.00
-13,110
1
$934.98M
2022-02-28
2022-03-02
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-6,555
$2.00
-13,110
1
$934.98M
2022-02-28
2022-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-7,400
$2.00
-14,800
1
$934.98M
2022-02-28
2022-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Employee Stock Option (Right to buy)
225K
$0.00
1
$934.98M
2022-02-28
2022-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
60,000
$0.00
1
$934.98M
2022-02-28
2022-03-02
COTREAU VIOLETTA
SVP, Chief Accounting Officer
A - Grant
Employee Stock Option (Right to buy)
70,000
$0.00
1
$934.98M
2022-02-28
2022-03-02
COTREAU VIOLETTA
SVP, Chief Accounting Officer
A - Grant
Common Stock
40,833
$0.00
1
$934.98M
2022-02-28
2022-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Employee Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2022-02-28
2022-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
50,000
$0.00
1
$934.98M
2022-02-28
2022-03-02
FAULKINGHAM DELL
SVP, CCO
A - Grant
Employee Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2022-02-28
2022-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Employee Stock Option (Right to buy)
200K
$0.00
1
$934.98M
2022-01-03
2022-01-05
COTREAU VIOLETTA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-5,833
$2.00
-11,666
1
$934.98M
2021-09-30
2021-10-01
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Employee Stock Option (Right to Buy)
200K
$0.00
1
$934.98M
2021-08-31
2021-09-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-1,042
$3.00
-3,126
1
$934.98M
2021-06-02
2021-06-03
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to buy)
20,100
$0.00
1
$934.98M
2021-04-01
2021-04-01
SPELLMAN DAVID
SVP, CFO and Treasurer
S - Sale
Common Stock
-790
$3.00
-2,370
1
$934.98M
2021-04-01
2021-04-01
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-1,211
$3.00
-3,633
1
$934.98M
2021-04-01
2021-04-01
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-1,081
$3.00
-3,243
1
$934.98M
2021-04-01
2021-04-01
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-1,060
$3.00
-3,180
1
$934.98M
2021-03-16
2021-03-18
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
10,400
$0.00
1
$934.98M
2021-03-16
2021-03-18
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
11,648
$0.00
1
$934.98M
2021-03-16
2021-03-18
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Common Stock
10,192
$0.00
1
$934.98M
2021-03-16
2021-03-18
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Common Stock
7,592
$0.00
1
$934.98M
2021-03-01
2021-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,558
$3.00
-22,674
1
$934.98M
2021-03-01
2021-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-14,547
$3.00
-43,641
2
$934.98M
2021-03-01
2021-03-02
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-14,285
$3.00
-42,855
2
$934.98M
2021-02-26
2021-03-02
FAULKINGHAM DELL
CCO
A - Grant
Employee Stock Option (Right to buy)
110K
$0.00
1
$934.98M
2021-02-26
2021-03-02
COTREAU VIOLETTA
SVP, Chief Accounting Officer
A - Grant
Employee Stock Option (Right to buy)
44,200
$0.00
1
$934.98M
2021-02-26
2021-03-02
COTREAU VIOLETTA
SVP, Chief Accounting Officer
A - Grant
Common Stock
26,000
$0.00
1
$934.98M
2021-02-26
2021-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Employee Stock Option (Right to buy)
110K
$0.00
1
$934.98M
2021-02-26
2021-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
62,000
$0.00
1
$934.98M
2021-02-26
2021-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Employee Stock Option (Right to buy)
120K
$0.00
1
$934.98M
2021-02-26
2021-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
70,000
$0.00
1
$934.98M
2021-02-26
2021-03-02
BUTLER JOHN
CEO and President
A - Grant
Employee Stock Option (Right to buy)
404K
$0.00
1
$934.98M
2021-02-26
2021-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Employee Stock Option (Right to buy)
110K
$0.00
1
$934.98M
2021-02-26
2021-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Common Stock
62,000
$0.00
1
$934.98M
2021-02-26
2021-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Employee Stock Option (Right to buy)
120K
$0.00
1
$934.98M
2021-02-26
2021-03-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Common Stock
70,000
$0.00
1
$934.98M
2020-06-30
2020-07-02
SPELLMAN DAVID
SVP, CFO and Treasurer
A - Grant
Employee Stock Option (Right to buy)
280K
$0.00
1
$934.98M
2020-06-05
2020-06-09
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to buy)
20,100
$0.00
1
$934.98M
2020-02-28
2020-03-02
AMELLO JASON
SVP, CFO & Treasurer
S - Sale
Common Stock
-6,976
$9.00
-62,784
1
$934.98M
2020-02-28
2020-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
S - Sale
Common Stock
-6,972
$9.00
-62,748
1
$934.98M
2020-02-28
2020-03-02
HADAS NICOLE
SVP, Chief Legal Officer
S - Sale
Common Stock
-7,050
$9.00
-63,450
1
$934.98M
2020-02-28
2020-03-02
TUBRIDY KAREN
SVP, Chief Development Officer
S - Sale
Common Stock
-3,454
$9.00
-31,086
1
$934.98M
2020-02-28
2020-03-02
AMELLO JASON
SVP, CFO & Treasurer
A - Grant
Stock Option (Right to buy)
45,000
$0.00
1
$934.98M
2020-02-28
2020-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to buy)
106K
$0.00
1
$934.98M
2020-02-28
2020-03-02
BURKE STEVEN KEITH
SVP, Chief Medical Officer
A - Grant
Common Stock
62,000
$0.00
1
$934.98M
2020-02-28
2020-03-02
BUTLER JOHN
CEO and President
A - Grant
Stock Option (Right to buy)
404K
$0.00
1
$934.98M
2020-02-28
2020-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Stock Option (Right to buy)
120K
$0.00
1
$934.98M
2020-02-28
2020-03-02
DAHAN MICHEL
SVP, Chief Operating Officer
A - Grant
Common Stock
65,000
$0.00
1
$934.98M
2020-02-28
2020-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Stock Option (Right to buy)
105K
$0.00
1
$934.98M
2020-02-28
2020-03-02
HADAS NICOLE
SVP, Chief Legal Officer
A - Grant
Common Stock
62,000
$0.00
1
$934.98M
2020-02-28
2020-03-02
TUBRIDY KAREN
SVP, Chief Development Officer
A - Grant
Stock Option (Right to buy)
85,000
$0.00
1
$934.98M
2020-02-28
2020-03-02
TUBRIDY KAREN
SVP, Chief Development Officer
A - Grant
Common Stock
30,000
$0.00
1
$934.98M